SOLARA ACTIVE PHARMA SCIENCES
Quarterly Results Analysis [Dec2023]
SOLARA ACTIVE PHARMA SCIENCES Quarterly Results
Consolidated | Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 UnAudited |
Dec2022 UnAudited |
Sep2022 UnAudited |
Jun2022 UnAudited |
Mar2022 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹249 Cr | ₹425 Cr | ₹352 Cr | ₹381 Cr | ₹395 Cr | ₹338 Cr | ₹330 Cr | ₹361 Cr |
Expenses | ₹410 Cr | ₹388 Cr | ₹333 Cr | ₹332 Cr | ₹350 Cr | ₹311 Cr | ₹318 Cr | ₹347 Cr |
Operating Income | ₹-162 Cr | ₹38 Cr | ₹19 Cr | ₹49 Cr | ₹45 Cr | ₹28 Cr | ₹13 Cr | ₹14 Cr |
Other Income | ₹0 Cr | ₹1 Cr | ₹2 Cr | ₹5 Cr | ₹7 Cr | ₹4 Cr | ₹7 Cr | ₹6 Cr |
Interest | ₹25 Cr | ₹24 Cr | ₹25 Cr | ₹22 Cr | ₹24 Cr | ₹22 Cr | ₹23 Cr | ₹21 Cr |
Depreciation | ₹26 Cr | ₹26 Cr | ₹26 Cr | ₹26 Cr | ₹28 Cr | ₹29 Cr | ₹28 Cr | ₹28 Cr |
Profit Before Tax | ₹-275 Cr | ₹-17 Cr | ₹-29 Cr | ₹5 Cr | ₹1 Cr | ₹-19 Cr | ₹-31 Cr | ₹-31 Cr |
Profit After Tax | ₹-275 Cr | ₹-17 Cr | ₹-19 Cr | ₹4 Cr | ₹0 Cr | ₹-10 Cr | ₹-16 Cr | ₹2 Cr |
EPS | ₹-76.48 | ₹-4.77 | ₹-5.43 | ₹1.05 | ₹0.13 | ₹-2.77 | ₹-4.56 | ₹0.52 |
Industry Peers & Returns | 1W | 1M | 1Y |
SOLARA ACTIVE PHARMA SCIENCES | -3.2% | 39.7% | 46.6% |
SUN PHARMACEUTICAL INDUSTRIES | 1.1% | -6.6% | 56.7% |
CIPLA | 0.2% | -4.4% | 54.3% |
DR REDDYS LABORATORIES | 4.3% | 2.6% | 29.9% |
ZYDUS LIFESCIENCES | 2.2% | -4.6% | 86.6% |
DIVIS LABORATORIES | 4.8% | 18.9% | 23.9% |
MANKIND PHARMA | -1.4% | 1.4% | NA |
TORRENT PHARMACEUTICALS | -1.7% | 3% | 65.8% |
LUPIN | 4.1% | 3% | 131.2% |
SOLARA ACTIVE PHARMA SCIENCES Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -41.51 % |
Y-o-Y | -36.99 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2023 | ₹249 Cr | -41.51 | |
Sep2023 | ₹425 Cr | 20.70 | |
Jun2023 | ₹352 Cr | -7.44 | |
Mar2023 | ₹381 Cr | -3.58 | |
Dec2022 | ₹395 Cr | 16.66 | |
Sep2022 | ₹338 Cr | 2.51 | |
Jun2022 | ₹330 Cr | -8.52 | |
Mar2022 | ₹361 Cr | - |
SOLARA ACTIVE PHARMA SCIENCES Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2023 | ₹-162 Cr | Negative | |
Sep2023 | ₹38 Cr | 96.81 | |
Jun2023 | ₹19 Cr | -60.80 | |
Mar2023 | ₹49 Cr | 8.38 | |
Dec2022 | ₹45 Cr | 63.22 | |
Sep2022 | ₹28 Cr | 119.68 | |
Jun2022 | ₹13 Cr | -7.24 | |
Mar2022 | ₹14 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2023 | -65.01% | Negative | |
Sep2023 | 8.85% | 62.98 | |
Jun2023 | 5.43% | -57.61 | |
Mar2023 | 12.81% | 12.37 | |
Dec2022 | 11.4% | 39.88 | |
Sep2022 | 8.15% | 114.47 | |
Jun2022 | 3.8% | 1.33 | |
Mar2022 | 3.75% | - |
SOLARA ACTIVE PHARMA SCIENCES Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2023 | ₹-275 Cr | Negative | |
Sep2023 | ₹-17 Cr | Negative | |
Jun2023 | ₹-19 Cr | Negative | |
Mar2023 | ₹4 Cr | 774.42 | |
Dec2022 | ₹0 Cr | Positive | |
Sep2022 | ₹-10 Cr | Negative | |
Jun2022 | ₹-16 Cr | Negative | |
Mar2022 | ₹2 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2023 | -110.7 % | Negative | |
Sep2023 | -4.01 % | Negative | |
Jun2023 | -5.42 % | Negative | |
Mar2023 | 0.99 % | 800.00 | |
Dec2022 | 0.11 % | Positive | |
Sep2022 | -2.95 % | Negative | |
Jun2022 | -4.98 % | Negative | |
Mar2022 | 0.5 % | - |
SOLARA ACTIVE PHARMA SCIENCES Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2023 | ₹-76.48 | Negative | |
Sep2023 | ₹-4.77 | Negative | |
Jun2023 | ₹-5.43 | Negative | |
Mar2023 | ₹1.05 | 707.69 | |
Dec2022 | ₹0.13 | Positive | |
Sep2022 | ₹-2.77 | Negative | |
Jun2022 | ₹-4.56 | Negative | |
Mar2022 | ₹0.52 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD